Zevia PBC (NYSE:ZVIA – Get Free Report) has been given a consensus rating of “Hold” by the six brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $4.4250.
Several research firms recently weighed in on ZVIA. Weiss Ratings restated a “sell (d-)” rating on shares of Zevia PBC in a research note on Wednesday, January 21st. Telsey Advisory Group dropped their price target on shares of Zevia PBC from $6.00 to $5.00 and set an “outperform” rating on the stock in a research note on Thursday, February 26th. Finally, Craig Hallum initiated coverage on shares of Zevia PBC in a report on Thursday, January 15th. They set a “buy” rating and a $4.00 price objective on the stock.
Get Our Latest Analysis on ZVIA
Insider Buying and Selling at Zevia PBC
Institutional Trading of Zevia PBC
A number of large investors have recently made changes to their positions in ZVIA. Quadrature Capital Ltd purchased a new position in Zevia PBC during the 4th quarter worth approximately $26,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in Zevia PBC in the fourth quarter valued at approximately $27,000. Engineers Gate Manager LP acquired a new stake in shares of Zevia PBC in the fourth quarter valued at approximately $28,000. SG Americas Securities LLC purchased a new position in shares of Zevia PBC during the fourth quarter worth approximately $31,000. Finally, R Squared Ltd acquired a new position in shares of Zevia PBC in the 3rd quarter valued at $36,000. 53.21% of the stock is owned by institutional investors and hedge funds.
Zevia PBC Price Performance
Zevia PBC stock opened at $1.17 on Thursday. The stock has a market cap of $87.49 million, a PE ratio of -7.77 and a beta of 0.93. The stock’s fifty day moving average is $1.51 and its two-hundred day moving average is $2.08. Zevia PBC has a 1-year low of $1.11 and a 1-year high of $3.66.
Zevia PBC (NYSE:ZVIA – Get Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The company had revenue of $37.87 million during the quarter, compared to the consensus estimate of $39.96 million. Zevia PBC had a negative return on equity of 22.49% and a negative net margin of 6.15%. On average, research analysts expect that Zevia PBC will post -0.32 earnings per share for the current fiscal year.
About Zevia PBC
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Featured Stories
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
